| Name | Title | Contact Details |
|---|
STADCO is one of the leading companies in the Business Services sector.
Urgent Care Group (UCG) is a Nashville-based healthcare organization founded in 2017. It operates a network of over 50 urgent care centers across multiple states, partnering with regional health systems to provide fast, friendly, and affordable healthcare. UCG focuses on expanding access to high-quality care in growing communities, emphasizing efficiency and patient-centered service. The centers offer a range of services, including urgent care, injury treatment, illness management, and wellness/preventive services. Patients can receive care for infections, minor injuries, physicals, vaccinations, and screenings. UCG positions its services as cost-effective alternatives to emergency rooms, aiming to reduce wait times and improve accessibility. UCG values compassion, teamwork, and efficiency, with a mission to enhance the patient experience and foster community health. Recent expansions include partnerships with health systems like Northside Hospital in Georgia and Covenant Health in Tennessee, furthering their commitment to accessible healthcare.
RAVENTURES FAMILY AND PARTNERS American Builder: Reality-based construction show takes viewers onto the job site, into dust and debris, with host Brian Gurry as he experiences real commercial, residential and industrial projects ~ www.americanbuilde...
Viridian Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2006. Formerly known as Miragen Therapeutics, the company rebranded in January 2021. Viridian is dedicated to discovering, developing, and commercializing treatments for serious and rare diseases, utilizing its expertise in antibody discovery and protein engineering. The company’s product pipeline includes Veligrotug (VRDN-001), a monoclonal antibody in Phase 3 clinical trials for thyroid eye disease, and VRDN-003, a next-generation IGF-1R monoclonal antibody also in Phase 3 trials for the same condition. Additionally, Viridian is developing a portfolio of engineered anti-FcRn inhibitors, such as VRDN-006 and VRDN-008, aimed at treating various autoimmune diseases. Viridians mission is to deliver transformative therapies for patients with underserved diseases, emphasizing innovation and patient-centricity.
National Risk Services is a Saint Petersburg, FL-based company in the Business Services sector.